Jakarta, March 31, 2022 – PT Kalbe Farma Tbk and Subsidiaries (“Kalbe” or “the Company”) today announced that net sales reached Rp 26,261 billion in 2021, growing by 13.6% compared to 2020. Meanwhile, net income of the owners of the parent entity reached Rp 3,184 billion in 2021, grew by 16.5% compared to Rp 2,733 billion in 2020.